Latest Property Portfolio News

Page 1 of 29
Provaris Energy reported a $4.045 million loss for FY2026 as it progressed proprietary hydrogen and liquid CO₂ storage technologies, expanded strategic partnerships, and boosted cash reserves through multiple placements.
Maxwell Dee
Maxwell Dee
28 Aug 2026
Dexus has delivered a 37.0 cents per security distribution for FY26, matching guidance despite economic headwinds, while initiating a strategic review of infrastructure funds acquired in 2023 and forecasting lower earnings in FY27.
Eva Park
Eva Park
28 Aug 2026
Entropy Neurodynamics (ASX:ENP) reported a 30% rise in income and a narrower loss for FY26, driven by clinical progress in its IV-infused psilocin therapy TRP-8803, including promising Phase 2 results in Binge Eating Disorder and a new multi-indication basket study.
Ada Torres
Ada Torres
28 Aug 2026
Harvey Norman Holdings reported a 10.9% rise in profit before tax excluding one-off adjustments, driven by international retail growth and a robust property portfolio. The company declared a fully franked 13 cent final dividend, maintaining a strong balance sheet with conservative gearing.
Logan Eniac
Logan Eniac
28 Aug 2026
Actinogen Medical reported a $15.38 million loss for FY2026 while progressing its lead Alzheimer's drug Xanamem toward pivotal trial results expected this November. The company secured regulatory alignment and strengthened its cash position to fund operations through mid-2027.
Ada Torres
Ada Torres
27 Aug 2026
CTI Logistics (ASX:CLX) posted a 69% jump in net profit to $24 million for FY26, driven by robust transport volumes, logistics growth and a $74 million uplift in property valuations. The company also declared a 14 cents per share fully franked dividend.
Victor Sage
Victor Sage
26 Aug 2026
Desane Group Holdings posted a statutory net profit after tax of just $0.02 million for FY26, down sharply from $3.32 million the previous year, while advancing key property developments and maintaining a strong balance sheet.
Eva Park
Eva Park
26 Aug 2026
Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.
Ada Torres
Ada Torres
25 Aug 2026
K&S Corporation’s FY2026 profit fell 16% underlying, with a 31% dividend cut reflecting cautious outlook amid economic uncertainty and contract losses.
Victor Sage
Victor Sage
25 Aug 2026
WOTSO Group posted a 4% rise in operating income to $48.75 million for FY2026, cutting its net loss attributable to securityholders by 50% to $2.42 million. Distributions increased to 2.8 cents per stapled security, reflecting cautious progress in its suburban flexible workspace strategy.
Eva Park
Eva Park
25 Aug 2026
Property for Industry Limited (NZX: PFI) reported a resilient FY26, delivering a 14% rise in adjusted funds from operations per share and a 10.5% dividend increase, backed by strong portfolio occupancy and progress in green developments.
Eva Park
Eva Park
24 Aug 2026
Dexus (ASX: DXS) reported steady FY26 results with AFFO of 45.0 cents per security and distributions of 37.0 cents, while initiating a strategic review of infrastructure funds following an adverse APAC court judgment.
Eva Park
Eva Park
20 Aug 2026

Browse the archive

Full archive